{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:50:01Z","timestamp":1789732201468,"version":"4.0.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research Council of Lithuania","award":["No. S-LB-17-3"],"award-info":[{"award-number":["No. S-LB-17-3"]}]},{"name":"UNION STATE PROGRAM \u201cDNA IDENTIFICATION\u201d","award":["6.3"],"award-info":[{"award-number":["6.3"]}]},{"DOI":"10.13039\/100007595","name":"Belarusian Republican Foundation for Fundamental Research","doi-asserted-by":"publisher","award":["B17LITG-008"],"award-info":[{"award-number":["B17LITG-008"]}],"id":[{"id":"10.13039\/100007595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0221511","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T17:33:22Z","timestamp":1566495202000},"page":"e0221511","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Bone metabolism genes variation and response to bisphosphonate treatment in women with postmenopausal osteoporosis"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5973-7870","authenticated-orcid":true,"given":"Pavel","family":"Marozik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidmantas","family":"Alekna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ema","family":"Rudenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Tamulaitiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Rudenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asta","family":"Mastaviciute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volha","family":"Samokhovec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrejus","family":"Cernovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5819-6745","authenticated-orcid":true,"given":"Katsiaryna","family":"Kobets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Mosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,8,22]]},"reference":[{"key":"pone.0221511.ref001","volume-title":"World Health Organization Collaborating Centre for Metabolic Bone Diseases","author":"on behalf of the World Health Organization Scientific Group","year":"2007"},{"issue":"10","key":"pone.0221511.ref002","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/jbmr.1698","article-title":"Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention","volume":"27","author":"JA Eisman","year":"2012","journal-title":"Journal of bone and mineral research"},{"issue":"3","key":"pone.0221511.ref003","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5312\/wjo.v7.i3.171","article-title":"Major osteoporotic fragility fractures: Risk factor updates and societal impact","volume":"7","author":"P Pisani","year":"2016","journal-title":"World J Orthop"},{"issue":"1","key":"pone.0221511.ref004","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/11587570-000000000-00000","article-title":"Antifracture efficacy of currently available therapies for postmenopausal osteoporosis","volume":"71","author":"JY Reginster","year":"2011","journal-title":"Drugs"},{"issue":"5","key":"pone.0221511.ref005","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jbmr.11","article-title":"Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial","volume":"25","author":"AV Schwartz","year":"2010","journal-title":"Journal of bone and mineral research"},{"issue":"6","key":"pone.0221511.ref006","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00223-004-0286-7","article-title":"Seven years of treatment with risedronate in women with postmenopausal osteoporosis","volume":"75","author":"DD Mellstrom","year":"2004","journal-title":"Calcified tissue international"},{"issue":"2","key":"pone.0221511.ref007","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jbmr.1494","article-title":"The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)","volume":"27","author":"DM Black","year":"2012","journal-title":"Journal of bone and mineral research"},{"issue":"7","key":"pone.0221511.ref008","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0025-6196(11)60752-0","article-title":"Adverse effects of bisphosphonates: implications for osteoporosis management","volume":"84","author":"KA Kennel","year":"2009","journal-title":"Mayo Clinic proceedings"},{"issue":"1","key":"pone.0221511.ref009","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1755-7682-6-24","article-title":"Bisphosphonates adherence for treatment of osteoporosis","volume":"6","author":"HP Vieira","year":"2013","journal-title":"Int Arch Med"},{"issue":"2","key":"pone.0221511.ref010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00198-015-3271-2","article-title":"Natural history, reasons for, and impact of low\/non-adherence to medications for osteoporosis in a cohort of community-dwelling older women already established on medication: a 2-year follow-up study","volume":"27","author":"EM Clark","year":"2016","journal-title":"Osteoporosis international"},{"issue":"12","key":"pone.0221511.ref011","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00198-012-2093-8","article-title":"Treatment failure in osteoporosis","volume":"23","author":"A Diez-Perez","year":"2012","journal-title":"Osteoporosis international"},{"key":"pone.0221511.ref012","article-title":"Association between SOST gene polymorphisms and response to alendronate treatment in postmenopausal Chinese women with low bone mineral density","author":"WJ Wang","year":"2018","journal-title":"Pharmacogenomics J"},{"issue":"2","key":"pone.0221511.ref013","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/resp.12429","article-title":"Polymorphism of LRP5 gene and emphysema severity are associated with osteoporosis in Japanese patients with or at risk for COPD","volume":"20","author":"S Chubachi","year":"2015","journal-title":"Respirology"},{"issue":"4","key":"pone.0221511.ref014","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3760\/cma.j.issn.0366-6999.20132382","article-title":"Association of farnesyl diphosphate synthase polymorphisms and response to alendronate treatment in Chinese postmenopausal women with osteoporosis","volume":"127","author":"Y Liu","year":"2014","journal-title":"Chinese medical journal"},{"issue":"1","key":"pone.0221511.ref015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1001-9294(16)30016-5","article-title":"Association Between Geranylgeranyl Pyrophosphate Synthase Gene Polymorphisms and Bone Phenotypes and Response to Alendronate Treatment in Chinese Osteoporotic Women","volume":"31","author":"LW Han","year":"2016","journal-title":"Chinese medical sciences journal"},{"issue":"3","key":"pone.0221511.ref016","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/tpj.2010.88","article-title":"Common allelic variants of the farnesyl diphosphate synthase gene influence the response of osteoporotic women to bisphosphonates","volume":"12","author":"JM Olmos","year":"2012","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"pone.0221511.ref017","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s00223-001-1035-9","article-title":"COLIA1 Sp1 polymorphism predicts response of femoral neck bone density to cyclical etidronate therapy","volume":"70","author":"AM Qureshi","year":"2002","journal-title":"Calcified tissue international"},{"issue":"2","key":"pone.0221511.ref018","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/tpj.2014.52","article-title":"Genetic polymorphisms in the mevalonate pathway affect the therapeutic response to alendronate treatment in postmenopausal Chinese women with low bone mineral density","volume":"15","author":"C Wang","year":"2015","journal-title":"Pharmacogenomics J"},{"issue":"2","key":"pone.0221511.ref019","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10787-017-0322-7","article-title":"Polymorphisms in key bone modulator cytokines genes influence bisphosphonates therapy in postmenopausal women","volume":"25","author":"CA Lima","year":"2017","journal-title":"Inflammopharmacology"},{"issue":"7","key":"pone.0221511.ref020","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1210\/js.2018-00105","article-title":"Fibroblast Growth Factor 2 and Its Receptors in Bone Biology and Disease","volume":"2","author":"JD Coffin","year":"2018","journal-title":"J Endocr Soc"},{"issue":"10","key":"pone.0221511.ref021","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's Guide to Prevention and Treatment of Osteoporosis","volume":"25","author":"F Cosman","year":"2014","journal-title":"Osteoporosis international"},{"issue":"3","key":"pone.0221511.ref022","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jocd.2015.06.011","article-title":"Clinical Use of Quantitative Computed Tomography-Based Finite Element Analysis of the Hip and Spine in the Management of Osteoporosis in Adults: the 2015 ISCD Official Positions-Part II","volume":"18","author":"P Zysset","year":"2015","journal-title":"Journal of clinical densitometry"},{"issue":"1","key":"pone.0221511.ref023","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jocd.2007.12.007","article-title":"Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference","volume":"11","author":"S Baim","year":"2008","journal-title":"Journal of clinical densitometry"},{"issue":"5","key":"pone.0221511.ref024","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/bioinformatics\/btm025","article-title":"SNPassoc: an R package to perform whole genome association studies","volume":"23","author":"JR Gonzalez","year":"2007","journal-title":"Bioinformatics"},{"issue":"2","key":"pone.0221511.ref025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3349\/ymj.2010.51.2.231","article-title":"Genetic polymorphism of geranylgeranyl diphosphate synthase (GGSP1) predicts bone density response to bisphosphonate therapy in Korean women","volume":"51","author":"HJ Choi","year":"2010","journal-title":"Yonsei medical journal"},{"issue":"10","key":"pone.0221511.ref026","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2217\/pgs.15.76","article-title":"SOST polymorphisms and response to alendronate treatment in postmenopausal Chinese women with osteoporosis","volume":"16","author":"PR Zhou","year":"2015","journal-title":"Pharmacogenomics"},{"issue":"1","key":"pone.0221511.ref027","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/FPC.0000000000000181","article-title":"OPG, RANKL, and RANK gene polymorphisms and the bone mineral density response to alendronate therapy in postmenopausal Chinese women with osteoporosis or osteopenia","volume":"26","author":"H Zheng","year":"2016","journal-title":"Pharmacogenetics and genomics"},{"issue":"5","key":"pone.0221511.ref028","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1359\/jbmr.091040","article-title":"IL21R and PTH may underlie variation of femoral neck bone mineral density as revealed by a genome-wide association study","volume":"25","author":"Y Guo","year":"2010","journal-title":"Journal of bone and mineral research"},{"issue":"9","key":"pone.0221511.ref029","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1185\/03007990802352894","article-title":"Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis","volume":"24","author":"F Marini","year":"2008","journal-title":"Current medical research and opinion"},{"issue":"1","key":"pone.0221511.ref030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jbmr.186","article-title":"Polymorphisms in predicted miRNA binding sites and osteoporosis","volume":"26","author":"SF Lei","year":"2011","journal-title":"Journal of bone and mineral research"},{"issue":"1","key":"pone.0221511.ref031","doi-asserted-by":"crossref","DOI":"10.4238\/gmr.15017552","article-title":"Association of LRP5 Ala1330Val polymorphism with fracture risk: a meta-analysis","volume":"15","author":"J Peng","year":"2016","journal-title":"Genetics and molecular research: GMR"},{"issue":"3","key":"pone.0221511.ref032","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00223-008-9207-5","article-title":"LRP5 Polymorphisms and response to risedronate treatment in osteoporotic men","volume":"84","author":"M Kruk","year":"2009","journal-title":"Calcified tissue international"},{"issue":"3","key":"pone.0221511.ref033","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00223-008-9207-5","article-title":"LRP5 Polymorphisms and response to risedronate treatment in osteoporotic men","volume":"84","author":"M Kruk","year":"2009","journal-title":"Calcified tissue international"},{"issue":"11","key":"pone.0221511.ref034","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1093\/hmg\/ddt675","article-title":"Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS\/GENOMOS consortium","volume":"23","author":"A Moayyeri","year":"2014","journal-title":"Human molecular genetics"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0221511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T11:59:11Z","timestamp":1721649551000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0221511"}},"subtitle":[],"editor":[{"given":"Bart O.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,22]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0221511","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,22]]}}}